Vistagen Therapeutics
(OTC) VSTA
Vistagen Therapeutics Financials at a Glance
Market Cap
$23.24M
Revenue (TTM)
$1.74B
Net Income (TTM)
$488.28M
EPS (TTM)
$0.00
P/E Ratio
-0.37
Dividend
$0.00
Beta (Volatility)
2.19 (High)
Dividend
$0.00
Beta (Volatility)
2.19 (High)
Price
$0.59
Volume
6,830
Open
$0.59
Price
$0.59
Volume
6,830
Open
$0.59
Previous Close
$0.59
Daily Range
$0.59 - $0.60
52-Week Range
$0.43 - $5.14
Dividend
$0.00
Beta (Volatility)
2.19 (High)
Price
$0.59
Volume
6,830
Open
$0.59
Previous Close
$0.59
Daily Range
$0.59 - $0.60
52-Week Range
$0.43 - $5.14
VSTA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vistagen Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
59
CEO
Shawn K. Singh
Website
www.vistagen.comHeadquarters
São Paulo, SP 01310-100, BR
VSTA Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
20%
Net Income Margin
28%
Return on Equity
0%
Return on Capital
6%
Return on Assets
7%
Earnings Yield
-2.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.24M
Shares Outstanding
39.62M
Volume
6.83K
Short Interest
0.00%
Avg. Volume
900.58K
Financials (TTM)
Gross Profit
$1.02B
Operating Income
$365.72M
EBITDA
$606.80M
Operating Cash Flow
$175.44M
Capital Expenditure
$128.27M
Free Cash Flow
$47.17M
Cash & ST Invst.
$195.84M
Total Debt
$1.18B
Vistagen Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$249.60M
+13.4%
Gross Profit
$169.52M
+21.9%
Gross Margin
67.92%
N/A
Market Cap
$23.24M
N/A
Market Cap/Employee
$12.85K
N/A
Employees
1,808
N/A
Net Income
$59.77M
+22.5%
EBITDA
$52.26M
+38.1%
Quarterly Fundamentals
Net Cash
$807.51M
-1.5%
Accounts Receivable
$575.25M
+10.0%
Inventory
$288.04M
-14.0%
Long Term Debt
$828.47M
+40.4%
Short Term Debt
$369.91M
-34.0%
Return on Assets
7.03%
N/A
Return on Invested Capital
5.83%
N/A
Free Cash Flow
$75.01M
+60.7%
Operating Cash Flow
$96.31M
+41.0%